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RADIOBIOLOGY SPECIAL FEATURE: EDITORIAL
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Radiobiology is the study of the action of ionizing radiations
on living organisms and understanding it underpins the use
of ionizing radiations in diagnostics and therapy in radiation
oncology. The ﬁeld is going through a period of rapid change
and opportunity with new developments, feeding on the
latest biology, driving a greater mechanistic understanding
alongside advances in the clinical delivery of radiotherapy
and diagnostic imaging.
This timely special issue encapsulates some key advances in
radiobiology from the European Radiation Research Society,
which held its annual meeting (ERR2013) at Dublin Castle,
Dublin, Ireland 1–5 September 2013. International dele-
gates, including scientists and clinicians, had the opportu-
nity to hear the latest research in basic and translational
radiation biology over 15 sessions of plenary and keynote
lectures, proffered papers and posters. These sessions cov-
ered topics ranging from DNA damage and repair and non-
ionizing radiation to translational research and emerging
technologies.
This BJR special feature includes specially selected papers
from all the keynote and award lectures presented at the
meeting, giving a timely state-of-the-art overview of current
research and future directions in radiation biology, from
leaders in the ﬁeld.
Professor Penny Jeggo1 from the Genome Stability Unit at
the University of Sussex (Brighton, UK) gave the British
Institute of Radiology Silvanus ThompsonMemorial Lecture at
the meeting, and her review entitled “DNA DSB repair
pathway choice: an orchestrated handover mechanism”
gives a detailed molecular overview of the key mechanisms
determining the choice of DNA repair pathway in response
to radiation-induced DNA double-strand breaks.
The European Radiation Research Society Bacq and Alexander
Lecture was given by Professor Marco Durante2, from the
GSI Helmholtz Centre for Heavy Ion Research (Darmstadt,
Germany) and his review focuses on new challenges in high-
energy radiobiology. In particular, he reviews that densely
ionizing radiation elicits signalling pathways quite distinct
from those involved in the cell and tissue response to pho-
tons. There are also differences in the role of the microen-
vironment in individual susceptibility and a need to focus
more on tissue responses after ion-beam exposures.
The Association for Radiation Research Weiss Medal Lecture
was given by Professor Stephanie McKeown3 from the Uni-
versity of Ulster (Coleraine, UK) and covers the implications
for treatment response of how we deﬁne normoxia, physoxia
and hypoxia in tumours. Tumour hypoxia is increasingly
recognized as a major deleterious factor in cancer therapies,
as it compromises treatment and drives malignant pro-
gression. This review focuses on the need to determine the
consequences of the actual physiological levels of oxygen in
tissues (approximately 5%) and tumours (approximately 1%)
to identify the real circumstances driving tumour response
to treatment and/or malignant progression. This can be of
particular importance in genetic studies in vitro when
comparisons with human tumours are required.
Professor Jean-Luc Ravanat4, from CEA (Grenoble, France)
gives a review of the chemical aspects of radiation-mediated
formation of complex damage to DNA. In particular, he fo-
cuses on single oxidation events, as these lesions may play
a signiﬁcant role in cellular responses to ionizing radiation
and other oxidative stress agents.
Professor David Brenner5, from Columbia University (New
York, NY) gives a short overview of the inter-relationship
between exposure doses, the use of radiological imaging
techniques and the impact on radiation risk, which is an
increasingly important area given the increasing contribution
of medical exposures to the average background exposure
doses for the population in general.
Professor Martin Brown6, Stanford University (Stanford,
CA) gives an overview of the process of vasculogenesis, the
formation of blood vessels from circulating cells, which is
a crucial player in the resistance of solid tumours to radio-
therapy. Radiation recruits proangiogenic macrophages, and
endothelial progenitor cells reform the tumour vasculature
and allow the tumour to regrow following irradiation. This
is a new paradigm with major implications for the treatment of
solid tumours by radiotherapy.
The LH Gray Memorial Trust Lecture was given by Professor Rob
Bristow7 from the University of Toronto (Ontario, Canada). His
review entitled “An arranged marriage for precision medicine:
hypoxia and genomic assays in localized prostate cancer radio-
therapy” focuses on the need to improve treatment in-
dividualization for prostate cancer patients receiving radiotherapy
due to the 30–50% relapse rate. He outlines that better pre-
dictors of prognosis and radiotherapy treatment response are
needed to triage patients to bespoke and intensify calcium
monophosphide treatment protocols. In particular, these
should include the use of pre-treatment genomic tests based on
DNA or RNA indices and/or assays that reﬂect cancer metab-
olism, such as hypoxia assays, to deﬁne patient-speciﬁc pros-
tate cancer progression and aggression.
We hope that this collection of comprehensive review and opinion
articles, from leaders in the ﬁeld, sets the scene of where
radiobiology research stands at present and outlines future
progress.
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